Effects of advanced glycation end products on osteocytes mechanosensitivity

Xiao Yang1, Cong-Jin Liu1, Zhen-Zhen Wang1

  • 1Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing, China, 100083.

Insights

Advanced glycation end products (AGEs) impair osteocyte mechanosensitivity, disrupting bone remodeling. This study reveals AGEs negatively impact how osteocytes respond to mechanical stress, offering insights into osteoporosis mechanisms.

Area of Science:

  • Bone Biology
  • Cellular Mechanotransduction

Background:

  • Osteocytes are crucial mechanosensors regulating bone remodeling.
  • Advanced glycation end products (AGEs) can induce osteocyte apoptosis.
  • The impact of AGEs on osteocyte mechanosensitivity remains unclear.

Purpose of the Study:

  • To investigate the effects of AGEs on osteocyte mechanosensitivity.
  • To determine how AGEs influence osteocyte response to mechanical loading.
  • To elucidate AGEs' role in regulating bone remodeling markers.

Main Methods:

  • Osteocytic-like cells (MLO-Y4) were treated with varying AGE concentrations.
  • Cells were subjected to fluid shear stress (15 dyne/cm²).
  • Key mechanotransduction markers (F-actin, PGE2, NO, Wnt/β-catenin) and bone remodeling markers (OCN, RANKL/OPG) were analyzed.

Main Results:

  • AGEs inhibited osteocyte response to mechanical loading.
  • AGEs enhanced shear-induced Nitric Oxide (NO) and Prostaglandin E2 (PGE2) release.
  • AGEs suppressed Wnt/β-catenin pathway mechanosensitivity and promoted OCN and RANKL/OPG mRNA expression.

Conclusions:

  • AGEs adversely affect osteocyte mechanosensitivity and bone remodeling regulation.
  • AGE accumulation leads to negative effects on osteocytes under mechanical stimulation.
  • This study provides novel insights into osteoporosis mechanisms related to osteocyte dysfunction.

Related Concept Videos